[AI-generated content] The Federal Court of Australia has ruled that manufacturing processes for biosimilar Brenzys products do not infringe a Pfizer process patent. The decision in Pfizer Ireland Pharmaceuticals Unlimited Company v Samsung Bioepis Co., Ltd resolves claims over the production methods for the etanercept therapy Enbrel. The ruling provides clarity on the scope of ...
Subscribe to The Patent’s news feed.
Click on “Follow” and decide if you want to get news from The Patent via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to The Patent comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from The Patent which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: The Patent - International Magazine of World Inventions